We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-11.43%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$19.8B
AUM Growth
-$2.83B
Cap. Flow
+$212M
Cap. Flow %
1.07%
Top 10 Hldgs %
15.28%
Holding
2,395
New
108
Increased
1,282
Reduced
892
Closed
107

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$32.7M
2
CI icon
Cigna
CI
+$31.5M
3
LYB icon
LyondellBasell Industries
LYB
+$27.6M
4
VICI icon
VICI Properties
VICI
+$24.4M
5
CVS icon
CVS Health
CVS
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 17.58%
2 Financials 16.18%
3 Healthcare 14.54%
4 Consumer Discretionary 9.94%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFBC icon
2026
Preferred Bank
PFBC
$1.24B
$252K ﹤0.01%
5,802
+1,778
+44% +$90.8K
KEM
2027
DELISTED
KEMET Corporation
KEM
$252K ﹤0.01%
+14,339
New +$268K
MTSC
2028
DELISTED
MTS Systems Corp
MTSC
$252K ﹤0.01%
6,291
-1,691
-21% -$81.5K
ATRC icon
2029
AtriCure
ATRC
$2.08B
$251K ﹤0.01%
8,192
+2,126
+35% +$66.2K
PRAA icon
2030
PRA Group
PRAA
$672M
$251K ﹤0.01%
10,286
-6,008
-37% -$179K
CHSP
2031
DELISTED
Chesapeake Lodging Trust
CHSP
$251K ﹤0.01%
10,297
+887
+9% +$25.6K
AKRX
2032
DELISTED
Akorn Inc
AKRX
$250K ﹤0.01%
73,887
+11,457
+18% +$68.2K
PRFT
2033
DELISTED
Perficient Inc
PRFT
$249K ﹤0.01%
11,190
+1,741
+18% +$42.7K
GLRE icon
2034
Greenlight Captial
GLRE
$579M
$248K ﹤0.01%
28,763
+6,210
+28% +$67.8K
MNTA
2035
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$248K ﹤0.01%
22,448
-836
-4% -$11.6K
CNOB icon
2036
Center Bancorp
CNOB
$1.65B
$247K ﹤0.01%
13,368
-3,212
-19% -$65.8K
PR
2037
Permian Resources
PR
$17.4B
$247K ﹤0.01%
22,457
-3,314
-13% -$56.9K
AERI
2038
DELISTED
Aerie Pharmaceuticals
AERI
$247K ﹤0.01%
6,846
+1,591
+30% +$74.6K
MNR
2039
DELISTED
Monmouth Real Estate Investment Corp
MNR
$247K ﹤0.01%
19,914
-4,699
-19% -$68.4K
CXP
2040
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$246K ﹤0.01%
12,732
-4,823
-27% -$103K
UNVR
2041
DELISTED
Univar Solutions Inc.
UNVR
$245K ﹤0.01%
13,801
-3,488
-20% -$80.7K
SPN
2042
DELISTED
Superior Energy Services, Inc.
SPN
$245K ﹤0.01%
7,328
-59
-0.8% -$4.1K
MSBI icon
2043
Midland States Bancorp
MSBI
$697M
$244K ﹤0.01%
+10,903
New +$284K
PDM
2044
Piedmont Realty Trust
PDM
$1.24B
$244K ﹤0.01%
14,358
-10,014
-41% -$182K
SRCE icon
2045
1st Source
SRCE
$2.17B
$244K ﹤0.01%
6,056
+1,646
+37% +$76.6K
ROIC
2046
DELISTED
Retail Opportunity Investments Corp.
ROIC
$244K ﹤0.01%
15,365
-6,136
-29% -$108K
RUSHA icon
2047
Rush Enterprises Class A
RUSHA
$6.34B
$242K ﹤0.01%
+15,813
New +$253K
TROX icon
2048
Tronox
TROX
$967M
$242K ﹤0.01%
31,147
+11,845
+61% +$125K
CIVI
2049
DELISTED
Civitas Resources
CIVI
$241K ﹤0.01%
+11,681
New +$307K
HCC icon
2050
Warrior Met Coal
HCC
$4.17B
$241K ﹤0.01%
10,006
-3,120
-24% -$79.7K

Similar funds

Aperio Group's Q4 2018 Portfolio in Review

As of Q4 2018, Aperio Group held 2,395 positions worth $19.8B, down 12% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q4 2018 filing shows 108 new, 1,282 increased, 892 reduced and 107 closed positions. Its largest new stake was Linde: 206,771 shares worth $32.3M. The largest sale was Aetna Inc, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2018 buy was Linde: 206,771 shares worth $32.3M.
  • Aperio Group added most to Cigna in Q4 2018, an estimated $31.5M increase.
  • Aperio Group's biggest Q4 2018 reduction was Apple, cutting an estimated $28.3M.
  • Aperio Group fully exited Aetna Inc in Q4 2018, selling an estimated $67.4M.
  • Aperio Group's ten largest holdings make up 15% of its $19.8B portfolio in Q4 2018.
  • Aperio Group opened 108 new positions and closed 107 in Q4 2018.
  • Aperio Group's portfolio value fell 12% quarter-over-quarter to $19.8B.

Based on Aperio Group's 13F filing for Q4 2018, filed 14 Feb 2019.